Caroline A Hartill Net Worth

The estimated Net Worth of Caroline A Hartill is at least $457 Thousand dollars as of 29 May 2015. Caroline Hartill owns over 50,000 units of RTI Surgical stock worth over $456,625 and over the last 21 years Caroline sold RTIX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Caroline Hartill RTIX stock SEC Form 4 insiders trading

Caroline has made over 1 trades of the RTI Surgical stock since 2015, according to the Form 4 filled with the SEC. Most recently Caroline exercised 50,000 units of RTIX stock worth $309,000 on 29 May 2015.

The largest trade Caroline's ever made was exercising 50,000 units of RTI Surgical stock on 29 May 2015 worth over $309,000. On average, Caroline trades about 2,381 units every 0 days since 2004. As of 29 May 2015 Caroline still owns at least 145,422 units of RTI Surgical stock.

You can see the complete history of Caroline Hartill stock trades at the bottom of the page.

What's Caroline Hartill's mailing address?

Caroline's mailing address filed with the SEC is C/O REGENERATION TECHNOLOGIES INC, 1162 RESEARCH CIRCLE, ALACHUA, FL, 32615.

Insiders trading at RTI Surgical

Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper, and Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.

What does RTI Surgical do?

RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.

Complete history of Caroline Hartill stock trades at RTI Surgical

RTI Surgical executives and stock owners

RTI Surgical executives and other stock owners filed with the SEC include:

• Jonathon Singer,
  Chief Financial Officer, Chief Operating Officer
• John Varela,
  Executive Vice President - Global Operations
• Olivier Visa,
  Vice President - OEM, Sports and Donor Services
• Shirley Weis,
  Independent Director
• Thomas McEachin,
  Independent Director
• Mark Stolper,
  Lead Independent Director
• Paul Thomas,
  Independent Director
• Nicholas Valeriani,
  Independent Director
• Pawel Lewicki,
  Director
• Scott Durall,
  Chief Commercial Officer
• Bryan Cornwall,
  Executive Vice President - Research and Clinical Affairs
• Stuart Simpson,
  Chairman of the Board
• Molly Poarch,
  Director, Corporate Communications & Investor Relations
• Jeffrey Lightcap,
  Independent Director
• Brian Kushner,
  Director
• Ryan Bartolucci,
  Vice President - Finance, Corporate Controller
• Terry Rich,
  President, Chief Executive Officer, Director
• Lyle P. Luedeman,
  
• Dean H Bergy,
  Director
• Street Healthcare Partners ...,
  
• Christopher R Sweeney,
  Director
• Curtis M Selquist,
  Director
• Peter F Gearen,
  Director
• Brian K Hutchison,
  Chairman, President and CEO
• Camille Farhat,
  Chief Executive Officer
• Robert P Jordheim,
  Executive Vice President/CFO
• Roger W Rose,
  Vice President Donor Services
• Johannes Wynand Louw,
  Vice President Finance
• Kevin D Brandt,
  EVP CCO-Domestic Direct
• Joshua H De Rienzis,
  General Counsel
• Philip R Chapman,
  Director
• Ned Hoye Villers,
  Director
• Adrian J R Smith,
  Director
• Caroline A Hartill,
  V.P. Quality Assurance
• Julianne M Bowler,
  Director
• Roy D Crowninshield,
  Director
• Gregory P Rainey,
  Director
• Neal B Freeman,
  Director
• Michael J La Prade,
  Vice President
• Holdings Inc Zimmer,
  10% owner
• Roderick N Allen,
  Vice President
• David J Simpson,
  Director
• Guy L Mayer,
  President
• Michael J Odrich,
  Director
• Lee Robert Jr Johnston,
  Vice President
• Udo Henseler,
  Director
• Christie J Blakely,
  Vice President
• Robert J Lane,
  Vice President
• Tara Leigh Zerby,
  VP, Xenograft Technologies
• Carolyn Shaffer,
  Vice President, Human Resource
• Thomas F Rose,
  Vice President and CFO
• Michael T Manley,
  Director
• Louis E Barnes,
  Vice President-Cardiovascular
• Charles Randal Mills,
  V.P. of Business Development
• William Melendez,
  Vice President, Research & Dev
• Jeffrey Michael Schumm,
  Vice Pres. and General Counsel
• Joseph W Condon,
  Vice President-Operations